Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5445_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •Abstract
- •1.1 Introduction
- •1.1.1 Historical Background
- •1.3.2 Pulmonary Drug Delivery
- •1.3.3 Parenteral Drug Delivery
- •1.4 Inulin Health Benefits
- •1.4.1 Prebiotic Effects
- •1.5 Inulin Industrial Applications
- •1.5.2 Pharmaceutical Uses
- •1.6.2 Regulatory Status Worldwide
- •1.7.1 Emerging Health Benefits
- •1.8 Conclusion
- •References
- •1.3 Inulin Drug Delivery Routes
- •1.3.1 Oral Drug Delivery
- •Abstract
- •2.1 Introduction
- •2.4 Physicochemical Characteristics
- •2.4.1 Chain Length
- •2.4.2 Solubility
- •2.4.3 Viscosity
- •2.4.4 Melting Temperature
- •2.4.5 Gelling
- •2.5.1 Extraction Through Hot Water
- •2.5.2 Extraction Using Ultrasound
- •2.5.3 Extraction Directed Through Microwave
- •2.7.1 Therapeutic Benefits
- •2.7.1.2 As Laxative
- •2.7.1.3 In Lipid Metabolism
- •2.7.1.5 Absorption Enhancer
- •2.8 Pharmaceutical Benefits
- •2.8.3 In PEGylation
- •2.8.5 As Gel
- •2.9 Diagnostic Benefits
- •2.10.2 Yield Variability
- •2.10.3 Purity Challenges
- •2.11 Future Scope
- •2.12 Conclusion
- •References
- •Abstract
- •3.1 Introduction
- •3.2 Inulin-Based Drug Formulations
- •3.3.1 Inulin-Based Hydrogels
- •3.3.2 Inulin-Based Micelles
- •3.3.3 Inulin-Based Liposomes
- •3.3.4 Inulin-Based Prodrugs
- •3.3.5 Inulin-Based Chelating Agents
- •3.3.6 Inulin-Based Microparticles
- •3.3.7 Inulin-Based Nanoparticles
- •3.6 Conclusions
- •References
- •Abstract
- •4.1 Introduction
- •4.3.1 Emulsifying Properties
- •4.3.3 Particle Stabilization
- •4.5.1 Solid Dosage Forms
- •4.5.3 Parenteral Formulations
- •4.5.4 Drug Delivery Systems
- •4.6.1 Skin Care Products
- •4.6.2 Hair Care Products
- •4.6.3 Personal Hygiene Products
- •4.7.2 Blood Sugar Regulation
- •4.9 Conclusion
- •References
- •Abstract
- •5.1 Introduction
- •5.5 Inulin-Based Drug Delivery Systems
- •5.5.1 Inulin Film Coating Agents
- •5.5.2 Biodegradable Inulin Coatings
- •5.5.3 Multipulse Delivery
- •5.5.4 Functional Inulin Coating Materials
- •5.5.5 Inulin Enteric Coatings/Colon Targeting
- •5.5.6 Tumor Targeting
- •5.5.7 Inulin Sustained Release Coatings
- •5.5.8 Hybrid Inulin-Based Coating Materials
- •5.5.9 Inulin Taste-Masking Coatings
- •5.5.10 Nanotechnology Using Inulin
- •5.7.1 Agriculture
- •5.7.2 Diagnosis
- •5.7.3 MRI Diagnosis
- •5.7.4 Medicine
- •5.7.5 Bioremediation
- •References
- •Abstract
- •Abbreviations
- •6.1 Introduction
- •6.1.1 Background
- •6.2 Understanding Prebiotics
- •6.4.2 Fermentation by Gut Microbiota
- •6.6.1 Bidirectional Communication
- •6.8 Future Perspective
- •6.9 Conclusion
- •References
- •7.2.2 Anti-Inflammatory Effects
- •7.3.1 Skin Whiteners
- •7.3.2 Hair Care
- •7.4 Regulatory Status
- •7.5 Conclusion
- •References
- •Abstract
- •7.1 Introduction
- •Abstract
- •8.1 Introduction
- •8.2.3 Anatomical Characteristics
- •8.2.4 Thermodynamic Stability
- •8.4.2 Formulation Strategies
- •8.5.3 Regulatory Considerations
- •8.9 Regulatory Considerations
- •8.11 Conclusion
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Inulin-Based Pharmaceutical Applications
- •9.3.1.1 GIT
- •9.3.1.2 CNS
- •9.3.1.3 CVS
- •9.3.1.4 Hypersensitivity Reactions
- •9.3.1.5 Other Reported Adverse Effects
- •9.3.2 Inulin Interactions
- •9.4.1 Acceptable Daily Intake
- •9.4.3.2 Adults
- •9.4.3.3 Elderly Individuals
- •9.4.3.4 Pregnant or Lactating Women
- •9.5.1 Clinical Trial Outcome
- •9.5.2 Animal Studies
- •9.5.3 In Vitro Studies
- •9.6 Future Prospects
- •9.7 Conclusion
- •References
- •Abstract
- •Abbreviations
- •10.1 Introduction
- •10.2.2.1 Prebiotic Activity
- •10.2.2.2 Improved Gut Health
- •10.2.2.3 Anti-Inflammatory Effects
- •10.2.2.5 Enhanced Mineral Absorption
- •10.6.1 Potential Side Effects
- •10.6.2 Dosage Recommendations
- •10.7 Future Perspective
- •10.8 Conclusion
- •References
- •Abstract
- •11.19.1 Tolerance
- •11.20 Conclusion
- •References
- •Abstract
- •12.1 Introduction
- •12.5.1 Hydrogels
- •12.5.2 Microparticles
- •12.5.3 Nanoparticles
- •12.5.4 Inulin Conjugates
- •12.5.5 Miscellaneous
- •12.7 Conclusion
- •References
- •Abstract
- •13.5.1 Pharmaceutical Quality Assurance Framework
- •References
- •Abstract
- •14.1 Introduction
- •14.2.1 Prebiotic Nature
- •14.8 Immune-Modulatory Effects
- •14.9.3 Addressing Bone-Related Disorders
- •14.12 Cognitive Implications
- •14.13 Future Directions
- •14.14 Conclusion
- •References
- •Abstract
- •15.1 Introduction
- •15.3 Extraction Techniques
- •15.7.1 In Pharmaceutical Sector
- •15.7.1.4 As Vaccine Adjuvant
- •15.7.2 In Food Sector
- •References
- •Abstract
- •16.1 Introduction
- •16.1.3 Innovative Drug Delivery Systems
- •16.2 Functional Properties
- •16.2.1 Liquidity
- •16.2.2 Prebiotic Characteristics
- •16.2.3 Low Energy Density
- •16.2.5 Potential Health Benefits
- •16.3.3 Mucosal Delivery Systems
- •16.3.4 Liposomes
- •16.5 Future Perspectives
- •References

66
low bioavailability (Leyva Porras etal. 2021). Methods like solid dispersion can
improve the medications’ release pattern and facilitate their disintegration. The
solid dispersion dissolves more quickly when hydrophilic carriers are used, which
boosts bioavailability. Additionally, because inulin is hydrophilic, dosage forms
employ it as a carrier to progressively improve medication release, solubility, and
bioavailability. Inulin considerably enhanced the solubility characteristics in a diaz-
epam dissolving rate investigation when contrasted with sucrose or other carbohy-
drates. Additionally, a research showed that employing solid dispersion tablets with
inulin DP23 signicantly improved the way that diazepam dissolved. Merely
10–15% of the medication is discharged from physical blends; however, 80–85% of
the release is observed from solid dispersions including inulin. A comparison of the
dissolution and stability characteristics of fenobrate utilizing many carriers,
including PEG 20k, PVP K30, HP-β-CD, mannitol, and inulin 4kDa, revealed that
the inulin carrier had superior stability and good solubility. In the trials on irbesar-
tan, inulin analogues showed qualities of regulated release. Although poly (acrylic
acid) grafting inulin may produce roughly 33% controlled release of irbesartan, its
disintegration rate of irbesartan exceeded 90% in 60min.
3.5.5 Inulin Use forMeasuring Glomerular Filtration Rate (GFR)
In human beings, inulin can only be eliminated via the kidneys. It is known that
inulin will pass through the glomerulus and not be taken up again by the tubules of
the kidney. Thus, the most accurate material for clinically assessing kidney function
by GFR measurement is inulin. It is administered intravenously in this instance
(Giang etal. 2014). Despite being widely acknowledged as the gold standard for
determining GFR clinically, inulin requires intricate techniques and is insufcient
for regular clinical evaluation. In recent years, scientists improved the method and
used near-IR dye-labeled inulin as an optical sensor to reliably measure GFR using
a transcutaneous pulse dye densitometer (Hauser Kawaguchi etal. 2019).
3.5.6 Adjuvants forVaccines
Adjuvants for vaccines are substances that boost specic immune responses to a
specic antigen. At present, the only vaccination adjuvants that the Food and Drug
Administration (FDA) has authorized are aluminum salts. The remainders are all
deemed preliminary and require more preclinical testing. They can be used in con-
junction with special vaccinations that have a number of advantages, such as reduc-
ing the need for antigens, quickly boosting immunity, fortifying the immune
response, and prolonging the antigen’s continual release (Skwarczynski 2017;
Sharma etal. 2024).
A new adjuvant called AdvaxTM is made from semicrystalline delta inulin par-
ticles. Without causing local or systemic reactogenicity, Advax improved humoral
and cellular immunity to the hepatitis B surface antigen (HBsAg) in animal
P. Sharma et al.

67
experiments. In a group of healthy adult volunteers, this rst-in-man Phase 1 clini-
cal research evaluated the safety and tolerability of three intramuscular doses of
HBsAg compounded with Advax. Advax was well tolerated; no adverse events were
recorded in participants who received Advax, and injection site pain assessments
were not substantially different from those of those receiving HBsAg alone (Gordon
etal. 2014).
3.6 Conclusions
The use of inulin as a pharmaceutical carrier was the main topic of this chapter.
Because inulin includes a hydroxyl group, it may be readily modied chemically
and has great biocompatibility, molecular exibility, biodegradability, membrane-
stabilizing properties, and immunological modulating effects. For this reason, inu-
lin is a fantastic choice for use as a carrier for biomaterials and drug delivery
systems. Its range of uses can be increased by modifying its chemical composition.
The hydroxyl group serves as both an active site and a stabilizing component for the
modication of inulin. This allows for the development of inulin pharmacological
delivery systems, including as hydrogel, liposomes, micelles, prodrugs, micropar-
ticles, solid dispersion, and nanoparticles. Because of inulin’s extraordinary afnity
for the kidney, medications may be administered precisely to the kidney. The
hydroxyl group also plays a key role in the good expansion in water of hydrogels
made from inulin. Monocytes and macrophages are able to effectively absorb the
particles due to the range of sizes present in microparticles and nanoparticles. By
functionalizing the existing inulin analogues with targeting ligands like folic acid
and biotin, the targeting efcacy can be increased. By employing solid dispersions
formed of inulin, medicines with poor water solubility can have their bioavailability
and solubility increased. A crucial thing to remember is that additional investigation
is required to nd out if inulin can be administered under light control, pH targeting,
lysosome triggered, or both.
Acknowledgments The authors acknowledge in particular ShriRam College of Pharmacy,
Banmore, Morena, Madhya Pradesh, India, for encouraging us and providing necessary facilities.
Funding There was no funding for this project from any source.
References
Anjuomo F, Barclay TG, Parikh A, Song Y, Chung R, Wang L, Liu L, Hayball JD, Petrovsky N,
Garg S (2019b) Design and characterization of inulin conjugate for improved intracellular and
targeted delivery of pyrazinoic acid to monocytes. Pharmaceutics 11(5):243
Anjuomo F, Fouladian P, Parikh A, Barclay TG, Song Y, Garg S (2019a) Preparation and char-
acterization of oxidized inulin hydrogel for controlled drug delivery. Pharmaceutics 11(7):356
Akhgari A, Farahmand F, Garekani HA, Sadeghi F, Vandamme TF (2006) Permeability and swell-
ing studies on free lms containing inulin in combination with different polymethacrylates
aimed for colonic drug delivery. Eur J Pharm Sci 28(4):307–314
3 Inulin: AVersatile Polymer forDrug Delivery System

68
Akram W, Joshi R, Garud N (2019a) Inulin: a promising carrier for controlled and targeted drug
delivery system. J Drug Deliv Ther 9(1-S):437–441
Akram W, Joshi R, Garud N (2019b) Polyelectrolyte complexation and ionotropic gellation: the
potential novel approach to design hydrogel particulate for sustained, modulated drug delivery
system: a review. Int J Pharm Sci Res 7:3563–3574
Alhajamee M, Marai K, Al Abbas SM, Homayouni Tabrizi M (2022) Co-encapsulation of cur-
cumin and tamoxifen in lipid-chitosan hybrid nanoparticles for cancer therapy. Mater Technol
37(9):1183–1194
Amiri S, Nezamdoost-Sani N, Mostashari P, McClements DJ, Marszałek K, Mousavi Khaneghah A
(2024) Effect of the molecular structure and mechanical properties of plant-based hydrogels in
food systems to deliver probiotics: an updated review. Crit Rev Food Sci Nutr 64(8):2130–2156
An R, Zhou X, Zhang J, Yang Y, Lyu C, Wang D (2024) Restoration of intestinal microbiota after
inulin supplementation halted: the secondary effect of supplemented inulin. Mol Nutr Food
Res 68(7):e2400033
Barclay T, Ginic-Markovic M, Cooper P, Petrovsky N (2016) Inulin-a versatile polysaccharide
with multiple pharmaceutical and food chemical uses. J Excip Food Chem 1(3):27–50
Bhanja A, Sutar PP, Mishra M (2022) Inulin-A polysaccharide: review on its functional and prebi-
otic efcacy. J Food Biochem 46(12):e14386
Castelli F, Sarpietro MG, Micieli D, Ottimo S, Pitarresi G, Tripodo G, Carlisi B, Giammona G
(2008) Differential scanning calorimetry study on drug release from an inulin-based hydro-
gel and its interaction with a biomembrane model: pH and loading effect. Eur J Pharm Sci
35(1–2):76–85
Charoenwongpaiboon T, Wangpaiboon K, Panpetch P, Field RA, Barclay JE, Pichyangkura R,
Kuttiyawong K (2019) Temperature-dependent inulin nanoparticles synthesized by lactoba-
cillus reuteri 121 inulosucrase and complex formation with avonoids. Carbohydr Polym
223:115–144
Cho H, Lai TC, Tomoda K, Kwon GS (2015) Polymeric micelles for multi-drug delivery in cancer.
AAPS PharmSciTech 16:10–20
Corsi DM, Vander Elst L, Muller RN, van Bekkum H, Peters JA (2001) Inulin as a carrier for con-
trast agents in magnetic resonance imaging. Chemistry 7(1):64–71
Cui H, Liu S, Lv Y, Wu S, Wang L, Hao F, Liu P, Xiong W, Luo H (2020) Transfer hydrogenation of
cinnamaldehyde to cinnamyl alcohol in hydrophobically modied core-shell MOFs nanoreac-
tor: identication of the formed metal–N as the structure of an active site. J Catal 381:468–481
Dan A, Ghosh S, Moulik SP (2009a) Physicochemical studies on the biopolymer inulin: a critical
evaluation of its self-aggregation, aggregate-morphology, interaction with water, and thermal
stability. Biopolymers 91(9):687–699
Dan A, Ghosh S, Moulik SP (2009b) Physicochemistry of the interaction between inulin and alk-
yltrimethylammonium bromides in aqueous medium and the formed coacervates. J Phys Chem
B 113(25):8505–8513
Di Prima G, Saladino S, Bongiovì F, Adamo G, Ghersi G, Pitarresi G, Giammona G (2017) Novel
inulin-based mucoadhesive micelles loaded with corticosteroids as potential transcorneal per-
meation enhancers. Eur J Pharm Biopharm 117:385–399
Fares MM, Khanfar M (2011) Inulin and poly (acrylic acid) grafted inulin for dissolution enhance-
ment and preliminary controlled release of poorly water-soluble Irbesartan drug. Int J Pharm
410(1–2):206–211
Ge D, Zou L, Li C, Liu S, Li S, Sun S, Ding W (2018) Simulation of the osmosis-based drug
encapsulation in erythrocytes. Eur Biophys J 47:261–270
Ghali EN, Chauhan SC, Yallapu MM (2024) Inulin-based formulations as an emerging therapeutic
strategy for cancer: a comprehensive review. Int J Biol Macromol 259(Pt 1):129216
Giang I, Boland EL, Poon GM (2014) Prodrug applications for targeted cancer therapy. AAPS J
16:899–913
Gordon D, Kelley P, Heinzel S, Cooper P, Petrovsky N (2014) Immunogenicity and safety of
Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepati-
tis B surface antigen: a randomized controlled phase 1 study. Vaccine 32(48):6469–6477
P. Sharma et al.

69
Gruskiene R, Lavelli V, Sereikaite J (2024) Application of inulin for the formulation and delivery
of bioactive molecules and live cells. Carbohydr Polym 327:121670
Hamedi H, Moradi S, Hudson SM, Tonelli AE (2018) Chitosan based hydrogels and their applica-
tions for drug delivery in wound dressings: a review. Carbohydr Polym 199:445–460
Hartzell AL, Maldonado-Gómez MX, Yang J, Hutkins RW, Rose DJ (2013) In vitro digestion and
fermentation of 5-formyl-aminosailcylate-inulin: a potential prodrug of 5-aminosalicylic acid.
Bioact Carbohydr Diet Fibre 2(1):8–14
Hauser Kawaguchi A, Milne M, Li F, Lee TY, Luyt LG (2019) The development of a near-
infrared inulin optical probe for measuring glomerular ltration rate. Int J Biol Macromol
123:255–260
Hester SN, Mastaloudis A, Gray R, Antony JM, Evans M, Wood SM (2018) Efcacy of anthocy-
anin and prebiotic blend on the intestinal environment in obese male and female subjects. J
Nutr Metab 2018:7497260. https://doi.org/10.1155/2018/7497260
Hinrichs WL, Sanders NN, De Smedt SC, Demeester J, Frijlink HW (2005) Inulin is a promising
cryo-and lyoprotectant for PEGylated lipoplexes. J Control Release 103(2):465–479
Hirsjarvi S, Passirani C, Benoit JP (2011) Passive and active tumour targeting with nanocarriers.
Curr Drug Discov Technol 8(3):188–196
Hua S, Wu SY (2013) The use of lipid-based nanocarriers for targeted pain therapies. Front
Pharmacol 4:69399
Jackson CB, Farzan M, Chen B, Choe H (2022) Mechanisms of SARS-CoV-2 entry into cells. Nat
Rev Mol Cell Biol 23(1):3–20
Jiménez-Sánchez M, Pérez-Morales R, Goycoolea FM, Mueller M, Praznik W, Loeppert R,
Bermúdez-Morales V, Zavala-Padilla G, Ayala M, Olvera C (2019) Self-assembled high molec-
ular weight inulin nanoparticles: enzymatic synthesis, physicochemical and biological proper-
ties. Carbohydr Polym 215:160–169
Jing Z, Ma Y, Zhu J (2022) Application of a novel electrostatic dry powder coating technology on
capsules for enteric release. J Drug Deliv Sci Technol 68:103058
Kandasamy S, Naveen R (2022) A review on the encapsulation of bioactive components using
spray-drying and freeze-drying techniques. J Food Process Eng 45(8):e14059
Kim MR, Feng T, Zhang Q, Chan HY, Chau Y (2019) Co-encapsulation and co-delivery of peptide
drugs via polymeric nanoparticles. Polymers 11(2):288
Kruger CL (2002) Generally recognised as safe (GRAS) notication for Frutat
®
. Food and Drug
Administration, Arlington, VA
Lebdušková P, Kotek J, Hermann P, Vander Elst L, Muller RN, Lukeš I, Peters JA (2004) A gado-
linium (III) complex of a carboxylic-phosphorus acid derivative of diethylenetriamine cova-
lently bound to inulin, a potential macromolecular MRI contrast agent. Bioconjug Chem
15(4):881–889
Leyva Porras C, Lopez Pablos AL, Alvarez Salas C, Perez Urizar J (2021) Polysaccharides.
Polysaccharides 11:1–22
Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Polysaccharides-based nanoparticles as drug deliv-
ery systems. Adv Drug Deliv Rev 60:1650–1662
López-Molina D, Navarro-Martínez MD, Rojas-Melgarejo F, Hiner AN, Chazarra S, Rodríguez-
López JN (2005) Molecular properties and prebiotic effect of inulin obtained from artichoke
(Cynara scolymus L.). Phytochemistry 66(12):1476–1484
Maksimenko A, Dosio F, Mougin J, Ferrero A, Wack S, Reddy LH, Weyn AA, Lepeltier E,
Bourgaux C, Stella B, Cattel L (2014) A unique squalenoylated and nonpegylated doxorubi-
cin nanomedicine with systemic long-circulating properties and anticancer activity. Proc Natl
Acad Sci USA 111:217–226
Mandracchia D, Tripodo G, Trapani A, Ruggieri S, Annese T, Chlapanidas T, Trapani G, Ribatti D
(2016) Inulin based micelles loaded with curcumin or celecoxib with effective anti-angiogenic
activity. Eur J Pharm Sci 93:141–146
Maris B, Verheyden L, Van Reeth K, Samyn C, Augustijns P, Kinget R, Van den Mooter G (2001)
Synthesis and characterisation of inulin-azo hydrogels designed for colon targeting. Int J
Pharm 213:143–152
3 Inulin: AVersatile Polymer forDrug Delivery System

70
Marteau P, Jacobs H, Cazaubiel M, Signoret C, Prevel JM, Housez B (2011) Effects of chic-
ory inulin in constipated elderly people: a double-blind controlled trial. Int J Food Sci Nutr
62(2):164–170
Maurer JM, Hofman S, Schellekens RCA, Tonnis WF, Dubois AOT, Woerdenbag HJ, Hinrichs WL,
Kosterink JG, Frijlink HW (2016) Development and potential application of an oral ColoPulse
iniximab tablet with colon specic release: a feasibility study. Int J Pharm 505:175–186
Mensink MA, Frijlink HW, van der Voort MK, Hinrichs WL (2015a) Inulin, a exible oligosac-
charide I: review of its physicochemical characteristics. Carbohydr Polym 130:405–419
Mensink MA, Frijlink HW, van der Voort MK, Hinrichs WL (2015b) Inulin, a exible oligosac-
charide. II: review of its pharmaceutical applications. Carbohydr Polym 134:418–428
Mensink MA, Frijlink HW, Van Der Voort MK, Hinrichs WLJ (2015c) Inulin, a exible oligosac-
charide. II: a review of its pharmaceutical applications. Carbohydr Polym 134:418–428
Mufamadi MS, Pillay V, Choonara YE, Du Toit LC, Modi G, Naidoo D, Ndesendo VM (2011)
A review on composite liposomal technologies for specialized drug delivery. J Drug Deliv
2011:939851
Mutanda T, Mokoena MP, Olaniran AO, Wilhelmi BS, Whiteley CG (2014) Microbial enzymatic
production and applications of short-chain fructooligosaccharides and inulooligosaccharides:
recent advances and current perspectives. J Ind Microbiol Biotechnol 41(6):893–906
Oliveira SM, Gruppi A, Vieira MV, Matos GS, Vicente AA, Teixeira JA, Fuciños P, Spigno G,
Pastrana LM (2021) How additive manufacturing can boost the bioactivity of baked functional
foods. J Food Eng 294:110394
Pankaj S, Ashish D, Dheerendra R, Yogendra R, Ramakant JK, Kuldeep S (2015) Formulate and
evaluate orodispersible tablets of primaquine. Indo Am J Pharm Res 5(5):1625–1632
Paolini G, Shapland R, Van Hoorn W (2006) Global mapping of pharmacological space. Nat
Biotechnol 24:805–815
Peterson LW, McKenna CE (2009) Prodrug approaches to improving the oral absorption of antivi-
ral nucleotide analogues. Expert Opin Drug Deliv 6:405–420
Petrovsky N, Cooper PD (2015) Advax™, a novel microcrystalline polysaccharide particle engi-
neered from delta inulin, provides robust adjuvant potency together with tolerability and safety.
Vaccine 33(44):5920–5926
Pitarresi G, Tripodo G, Cavallaro G, Palumbo FS, Giammona G (2008) Inulin–iron complexes: a
potential treatment of iron deciency anaemia. Eur J Pharm Biopharm 68(2):267–276
Placzek AT, Ferrara SJ, Hartley MD, Sanford-Crane HS, Meinig JM, Scanlan TS (2016)
Sobetirome prodrug esters with enhanced blood–brain barrier permeability. Bioorg Med Chem
24(22):5842–5854
Rautio J, Kumpulainen H, Heimbach T, Oliyai R, Oh D, Järvinen T, Savolainen J (2008) Prodrugs:
design and clinical applications. Nat Rev Drug Discov 7(3):255–270
Ravi V, Kumar TP (2008) Inuence of natural polymer coating on novel colon targeting drug
delivery system. J Mater Sci Mater Med 19(5):2131–2136
Rivas CJ, Tarhini M, Badri W, Miladi K, Greige-Gerges H, Nazari QA, Rodríguez SA, Román RÁ,
Fessi H, Elaissari A (2017) Nanoprecipitation process: from encapsulation to drug delivery. Int
J Pharm 532(1):66–81
Sahiner N, Sagbas S, Yoshida H, Lyon LA (2014) Synthesis and properties of inulin based micro-
gels. Colloids Interface Sci Commun 2:15–18
Schacht E, Buys L, Vermeersch J, Remon JP (1984) Polymer-drug combinations: synthesis and
characterization of modied polysaccharides containing procainamide moieties. J Control
Release 1(1):33–46
Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S (2015) Advances and challenges of
liposome assisted drug delivery. Front Pharmacol 6:163819
Shang HM, Hu TM, Lu YJ, Wu HX (2010) Effects of inulin on performance, egg quality, gut
microora and serum and yolk cholesterol in laying hens. Br Poult Sci 51(6):791–796
Sharma P (2021) Modication of human behavior due to coronavirus outbreak: a brief study on
current scenario. Asian J Pharm 15(3)
P. Sharma et al.

71
Sharma P (2022) Applications of statistical tools for optimization and development of smart drug
delivery system. In: Smart drug delivery. Intech Open, London, p183
Sharma P (2023) Nanostructured biomaterials in drug delivery: current trends and upcoming pos-
sibilities. In: Engineered biomaterials: synthesis and applications. Springer Nature, Singapore,
pp261–280
Sharma P, Bhargava S, Parashar D, Mangal A (2017) Formulation and evaluation of nanoparticles
containing cyclophosphamide. WJPR 7(1):785–798
Sharma P, Dasputre N, Jain V (2024) Nanomedicine: concepts, characteristics, and regulatory
challenges. In: Smart nanocarrier for effective drug delivery. CRC Press, pp1–16
Sharma P, Jain V (2023) An overview of current advances and pharmaceutical uses of 3D and 4D
printing. Explor Med 4:560–575
Sharma P, Jain V, Jain S (2021) Fabrication, optimization and evaluation of chronotropic drug
delivery system of captopril. Int J Pharm Sci Res 12:2203–2210
Sharma P, Jain V, Tailang M (2022) Selection and role of polymers for designing of a drug carrier.
In: Drug carriesrs. IntechOpen. https://doi.org/10.5772/intechopen.103125
Sharma P, Jain V, Tailang M (2023a) Advancement of nanocarrier-based engineering for spe-
cic drug delivery for cancer therapy. In: Targeted cancer therapy in biomedical engineering.
Springer Nature, Singapore, pp465–486
Sharma P, Jain V, Tailang M (2023b) How articial intelligence is transforming medicine: the
future of pharmaceutical research. In: Industry 4.0 and healthcare: impact of articial intel-
ligence. Springer Nature, Singapore, pp133–150
Sharma P, Tailang M (2017) Opportunities and challenges to develop transdermal patch with nano-
carrier. WJPR 6(15):392–400
Sharma P, Tailang M (2020) Design, optimization and evaluation of buccal drug delivery system of
propranolol for hypertension treatment. Int J Pharm Sci Res 11(1):301–311
Sharma P, Tailang M (2022) Primaquine-loaded transdermal patch for treating malaria: design,
development, and characterization. Futur J Pharm Sci 8(1):43
Shivhare K, Garg C, Priyam A, Gupta A, Sharma AK, Kumar P (2018) Enzyme sensitive smart
inulin-dehydropeptide conjugate self-assembles into nanostructures useful for targeted deliv-
ery of ornidazole. Int J Biol Macromol 106:775–783
Singh RS, Singh T, Hassan M, Larroche C (2022) Biofuels from inulin-rich feedstocks: a compre-
hensive review. Bioresour Technol 346:126606
Skwarczynski M (2017) Inulin: a new adjuvant with unknown mode of action. EBioMedicine 15:8–9
Tardif H, Arnold C, Hayes C, Eagar K (2017) Establishment of the Australasian electronic persis-
tent pain outcomes collaboration. Pain Med 18(6):1007–1018
Tian B, Hua S, Tian Y, Liu J (2020) Chemical and physical chitosan hydrogels as prospective car-
riers for drug delivery: a review. J Mater Chem B 8(44):10050–10064
Tripodo G, Pasut G, Trapani A, Mero A, Lasorsa FM, Chlapanidas T, Trapani G, Mandracchia D
(2015) Inulin--α-tocopherol succinate nanomicelles as a platform for effective intravenous
administration of curcumin. Biomacromolecules 16:550–557
Tripodo G, Perteghella S, Grisoli P, Trapani A, Torre ML, Mandracchia D (2019) Drug delivery of
rifampicin by natural micelles based on inulin: physicochemical properties, antibacterial activ-
ity and human macrophages uptake. Eur J Pharm Biopharm 136:250–258
Van Den Mooter G, Vervoort L, Kinget R (2003) Characterization of methacrylated inulin hydro-
gels designed for colon targeting: in vitro release of BSA.Pharm Res 20:303–307
Varan G, Varan C, Bilensoy E (2019) Plant based natural polymeric nanoparticles as promising
carriers for anticancer therapeutics. In: Polymeric nanoparticles as a promising tool for anti-
cancer therapeutics. Elsevier, pp293–318
Vereyken IJ, Chupin V, Islamov A, Kuklin A, Hincha DK, de Kruijff B (2003) The effect of fructan
on the phospholipid organization in the dry state. Biophys J 85(5):3058–3065
Vermeersch J, Vandoorne F, Permentier D, Schacht E (1985) Macromolecular prodrugs of met-
ronidazole. 1. Esterication of hydroxyl containing polymers with metronidazole monosuc-
cinate. Bulletin des Sociétés Chimiques Belges 94(8):591–596
3 Inulin: AVersatile Polymer forDrug Delivery System

72
Wang D, Sun F, Lu C, Chen P, Wang Z, Qiu Y, Mu H, Miao Z, Duan J (2018) Inulin-based
glutathione- responsive delivery system for colon cancer treatment. Int J Biol Macromol
111:1264–1272
Wang L, Song Y, Parikh A, Joyce P, Chung R, Liu L, Anjuomo F, Hayball JD, Petrovsky N,
Barclay TG, Garg S (2019) Doxorubicin-loaded delta inulin conjugates for controlled and
targeted drug delivery: development, characterization, and invitro evaluation. Pharmaceutics
11(11):581
Xue M, Wang J, Huang M (2022) Inulin-modied liposomes as a novel delivery system for cin-
namaldehyde. Food Secur 11(10):1467
Yang Z, Su H, Lv Y, Tao H, Jiang Y, Ni Z, Peng L, Chen X (2023) Inulin intervention attenuates
hepatic steatosis in rats via modulating gut microbiota and maintaining intestinal barrier func-
tion. Food Res Int 163:112309
Zabot GL, Silva EK, Azevedo VM, Meireles MA (2016) Replacing modied starch by inulin as
prebiotic encapsulant matrix of lipophilic bioactive compounds. Food Res Int 85:26–35
Zhang L, Li G, Gao M, Liu X, Ji B, Hua R, Zhou Y, Yang Y (2016) RGD-peptide conjugated inulin-
ibuprofen nanoparticles for targeted delivery of Epirubicin. Colloids Surf B: Biointerfaces
144:81–89
Zhao M, Mu W, Jiang B, Zhou L, Zhang T, Lu Z, Jin Z, Yang R (2011) Purication and character-
ization of inulin fructotransferase (DFA III-forming) from Arthrobacter aurescens SK 8.001.
Bioresour Technol 102(2):1757–1764
Zylberberg C, Gaskill K, Pasley S, Matosevic S (2017) Engineering liposomal nanoparticles for
targeted gene therapy. Gene Ther 24(8):441–452
P. Sharma et al.

73
4
Inulin asStabilizer
BrahmaSrinivasaRaoDesu, RajkumarM.Biradar,
MethakuSundarrajaVijaykanth, PranshulSethi,
KarthikeyanKrishnan, S.Prema, HanamanthJ.Kallur,
andAmudhaSenthamaraikannan
Abstract
Many industries, most notably the food industry, are interested in inulin, a natu-
rally occurring polysaccharide made by plants, since it is a powerful stabilizer.
By altering the texture, improving the organoleptic qualities, and lengthening the
shelf life, adding it to cooking recipes can successfully stabilize the product.
Inulin’s unique structure, which is made up of β-(2→1) fructans, gives it the high
emulsication, hydrogen bonding, and water-binding qualities that enable it to
B. S. R. Desu
Department of Pharmacology, Hindu College of Pharmacy, Guntur, Andhra Pradesh, India
R. M. Biradar
Sri Siddhalingeshwar College of Pharmacy, Bidar, Karnataka, India
M. S. Vijaykanth
Steriscience Specialities Private Limited, Bangalore, Karnataka, India
P. Sethi
Department of Pharmacology, College of Pharmacy, Shri Venkateshwara University
Afliation, Gajraula, Uttar Pradesh, India
K. Krishnan
Department of Pharmacology, PSM College of Dental Science and Research,
Thrissur, Kerala, India
S. Prema
Crescent School of Pharmacy, BS Abdur Rahman Crescent Institute of Science and
Technology, Chennai, Tamil Nadu, India
e-mail: prema.pharm@crescent.education
H. J. Kallur
RMES College of Pharmacy, Kalaburagi, Karnataka, India
A. Senthamaraikannan (*)
Department of Pharmaceutics, School of Pharmacy, Sathyabama Institute of Science and
Technology, Chennai, Tamil Nadu, India

74
form microgel networks. Inulin is a very capable polymer for minimizing or
preventing serum separation in reconstituted suspensions and emulsions; how-
ever, inulin produced the highest consistency. Food products have more texture
and consistency when inulin is used as stabilizer. Additionally, the prebiotic
qualities of inulin could be benecial to health. With all these benets, inulin has
shown to be a great stand-in for stabilizing a variety of pharmaceutical, culinary,
and cosmetic compositions. In this section, the current status of research on the
stabilizing characteristics of inulin is outlined, with an emphasis on the disci-
plines’ potential applications and advancements in the future.
Keywords
Inulin · Stabilizer · Food industry · Functional properties · Health benets
4.1 Introduction
“Inulin” refers to all β-(2→1) linear fructans. It may be found in several plants, such
as asparagus, leeks, onion, wheat, garlic, cilantro, artichokes, and bananas. Rose, a
German chemist, found inulin for the rst time as a distinct component using a hot
water extract of the Inula helenium plant in 1804. In 1818, Thomson coined the term
inulin to describe the isolated molecule. Inulin, getting a nondigestible carbohy-
drate, corresponds to the intestinal ber category, therefore contributes to its health
advantages (Roberfroid 2005).
Inulin-freeze-dried powder was tested as a vaccine stabilizer and conrmed to be
acceptable for nasal medication administration. Audouy etal. (2011) employed inu-
lin as a freezing agent for stabilizing entire inactivated viral vaccines for nasal medi-
cation administration, and they discovered that it was efcient and effective without
the addition of adjuvants. Inulin has been used to coat tablets, capsules, as a tablet
binder, as well as a vaccine-stabilizing agent, in which it is utilized as a matrix
derived from solid dispersion, an intermediate, or a hydrogel.
Another investigation on inulin’s stabilization abilities found that it is more
effective than trehalose. The compaction behavior of inulin and trehalose, as well as
their inuence on loading bovine-isolated alkaline phosphate (BIAP), was detected.
Trehalose crystallizes when compacted and contains moisture, whereas inulin has
minimal friability, is stable at elevated relative humidities, and has an excellent
tabletting power. As a result, inulin outperformed trehalose as a BIAP stabilizer in
tablet form (Eriksson etal. 2003).
The uses of inulin are also being witnessed in pharmaceutical industries for
enhancing the shelf-life for preparations. Due to its ability to create strong compos-
ites and biological embedment, it can be applied in formulations for controlled
released in medicine delivery systems. Thus, due to the prebiotic attribute, inulin
has multiple health benets and is used often in nutritional products and nutraceuti-
cals (Mensink etal. 2015).
Cosmetics, which are made by the help of inulin, are smoother in texture and to
some extent rened such that it does not require much preparation in aesthetic
B. S. R. Desu et al.

75
methods. Because of its capacity to stabilize emulsions, together with its emollient
action, it is suitably applied in creams, lotions, moisturizers, and other related cos-
metic products. The change of modern trends for healthier and more environmen-
tally amicable components has gone in a more intensive use of inulin as a stabilization
agent (Sharma 2022).
The need for natural stabilizing is acting as a driver for clean-label products
among customers thereby pulling the demand forward. The gluten-free, made from
plants, non-genetically modied organism (GMO) substance that meets this need is
inulin. Its low dissolution and cytotoxicity can also be supported by the growing
concern of companies as well as consumers toward the state of the environment.
Due to this, it can be concluded that inulin could greatly contribute to the production
of green products for several industries based on sustainable production (Flamm
etal. 2001).
The major objective of this part is to provide a comprehensive view of the stabi-
lizing application of inulin. This encompasses the relative evaluation of its physico-
chemical properties, which are involved in stability control. These features would
assist in understanding how inulin interacts with other ingredients at various com-
positions to intensify stability and improve the completed product.
The initial part of the evaluation of inulin in this part addresses questions that are
basic to physicochemical makeup, namely, solidity within molecule weight, solubil-
ity, ability to hydrate, and rheological properties. The specic ways that inulin par-
ticipates in stabilizing shall be illustrated, and they include emulsication, gellation,
dispensing and stabilization of parts, and interaction with other parts/aqueous
media. The use of inulin as a stabilizer in a real-world medicine, food, and aesthet-
ics will be explained in the subsequent subtopics. Use of inulin in each of the usages
and examples as well as illustrations will also be used to explain how inulin func-
tions in real-life situations.
4.2 Physicochemical Properties ofInulin
Stevia-sweetened sugar-free chocolate was the rst use of the polysaccharide inulin.
Studies have demonstrated the effectiveness of inulin, a polymeric surfactant
derived from sugar, in the long-term stabilization of emulsions. Chocolates without
added sugar were made using polydextrose and inulin as bulking agents. The impact
of D-tagatose and inulin on the rheological, sensory, and physicochemical charac-
teristics of dark chocolate. The effects of inulin, polydextrose, and maltodextrin as
bulking agents on the rheological characteristics of chocolate formulations were
assessed by Farzanmehr and Abbasi (2009), who came to the conclusion that inulin
and polydextrose might be utilized to enhance the qualities of chocolate.
Inulin demonstrates good solubility in water, particularly at temperatures over
60°C.Intake is inuenced by polymerization degree; shorter monomers (like oligo-
fructose) dissolve more readily than longer ones. Inulin also retains water, which
improves the texture and moisture content of food products (Wada et al. 2003).
Signicant impacts of inulin can be observed in the rheological properties of
4 Inulin asStabilizer
Соседние файлы в папке Библиотека им академика М.И. Перельмана
